APOE and Alzheimer disease: We will provide selective reviews of the e2 associations with (1) longevity; (2) AD neuropathology, tauopathies, and other FTLDs, and CVD related tissue and vessel pathologies; (3) plasma ApoE level as a potential biomarker; (4) cognition and neuroimaging; and (5) non-neurologic pleiotropy.